(RTTNews) - PerkinElmer Inc. (PKI) said Thursday that it has received an emergency use authorization from the U.S. Food and Drug Administration for the PKamp Respiratory SARS-CoV-2 RT-PCR Panel 1 ...
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Technologies announces the launch of two RT-PCR assays to accurately diagnose respiratory diseases caused by SARS-CoV-2, Influenza virus or RSV. Since initial ...
(RTTNews) - PerkinElmer, Inc. (PKI) said Monday that its PKamp Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnostic or IVD device in more than 30 ...
Since the beginning of the COVID-19 pandemic in March, hospitals have used different testing methods to detect if someone has the virus. According to the city of Amarillo public health department’s ...
Please provide your email address to receive an email when new articles are posted on . The BD MAX Respiratory Viral Panel detected and differentiated between influenza A and B respiratory syncytial ...
Alpharetta, Ga.-based Provista Diagnostics, a clinical diagnostics lab owned by medical diagnostics company Todos Medical, cleared all necessary hurdles to begin producing its new respiratory test ...
BIRMINGHAM, Ala., Oct. 2, 2025 /PRNewswire/ -- Molecular Designs, a developer and manufacturer of molecular infectious disease assays, today announced it has submitted a 510(k) premarket notification ...
Multiplexed SARS-CoV-2, Influenza A/B, and RSV and Poliovirus Typing Assays (1, 2 and 3) for the Bio-Rad, QIAGEN, and Thermo PCR Platforms FORT COLLINS, Colo., Dec. 20, 2022 /PRNewswire/ -- GT ...
Last year, while experts were concerned about the “twindemic”, the flu season was virtually non-existent due to COVID-19 public health countermeasures. With COVID-19 vaccination rollouts and ...
For people with suspected community-acquired pneumonia (CAP) in the emergency department (ED), routine polymerase chain reaction (PCR) testing on lower respiratory tract samples led to faster and more ...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the PKamp™ Respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results